ILD-SARDs Registry and Biorepository
Recruiting
Observational Study
Interstitial Lung Disease
Systemic Autoimmune Disease
Rheumatic Diseases
Rheumatic Arthritis
Systemic Sclerosis
Autoimmune Myositis
Systemic Lupus Erythematosus
Usual Interstitial Pneumonia
Nonspecific Interstitial Pneumonia
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 252 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A complex interaction between demographic, environmental and genetic mechanisms impact the onset, severity and outcome of ILD-SARDs through dysregulation of the immune system and lung pro-biotic pathways. Comorbidity and genetic risk indicate that there are overlapping pathogenic mechanisms among SARDs, some of which underlie ILD in different SARDs.
The purpose of this biobank is to study the cli…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Must be aged 18 years or older
2. Diagnosis of ILD as confirmed by a chest CT
3. Either a defined SARD, an undifferentiated connective tissue disease or features of autoimmunity without meeting clinical criteria for SARD
4. Patient must be willing to give their informed conse…
Contacts